CCX282-B
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CCX282-B, covering 2025-03-06 to 2025-03-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease [Phase 2]